NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $77,388,000 | -23.1% | 1,357,691 | +7.7% | 0.93% | -22.3% |
| Q2 2018 | $100,618,000 | -7.9% | 1,260,091 | 0.0% | 1.20% | -11.4% |
| Q1 2018 | $109,212,000 | +76.2% | 1,260,091 | +40.4% | 1.35% | +72.7% |
| Q4 2017 | $61,983,000 | +37.8% | 897,791 | +81.4% | 0.78% | +82.3% |
| Q3 2017 | $44,977,000 | +14.8% | 494,900 | -6.0% | 0.43% | +4.6% |
| Q2 2017 | $39,172,000 | +437.3% | 526,300 | +576.5% | 0.41% | +395.2% |
| Q1 2017 | $7,290,000 | – | 77,800 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |